Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | treatment of aortic endothelial cells and aortic smooth muscle cells with human recombinant epidermal growth factor, fibroblast growth factor-2, vascular endothelial growth factor, lipopolysaccharide, angiotensin II or hydrogen peroxide for 24 hours does not significantly alter UCHL1 mRNA levels | Homo sapiens | |
tumor necrosis factor-alpha | treatment of cultured vascular smooth muscle cells for 24 and 48 hours does not significantly alter UCHL1 mRNA levels, whereas long term treatment (96 hours) significantly increases UCHL1 mRNA levels. Treatment of aortic endothelial cells and aortic smooth muscle cells with tumor necrosis factor-alpha for 24 hours does not significantly alter UCHL1 mRNA levels | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | overexpression of UCHL1 significantly attenuates tumor necrosis factor-alphainduced nuclear factor-kappa B activity in vascular cells and increases inhibitor of kappa B-alpha, possibly through the attenuation of kappa B-alpha ubiquitination, leading to decreased neointima in the balloon-injured artery | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expressed in BAEC cells | Homo sapiens |
human UCHL1 and bovine eNOS subcloned into D-TOPO and transferred into the mammalian expression vector pcDNA3.1 or pCAGGS, transfection of plasmid DNA in rat carotid artery | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
siRNA | knockdown of UCHL1 by small interfering RNA results in increased nuclear factor-kappa B activity in A7r5 cells | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
nucleus | - |
Homo sapiens | 5634 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
aortic endothelial cell | mRNA and protein expression, expressed in endothelial cells in atherosclerotic lesions from human carotid arteries | Homo sapiens | - |
aortic smooth muscle | mRNA and protein expression | Homo sapiens | - |
brain | - |
Homo sapiens | - |
additional information | vasculature | Homo sapiens | - |
vascular smooth muscle cell | mRNA and protein expression, expressed in vascular smooth muscle cells in atherosclerotic lesions from human carotid arteries | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
inhibitor of kappa B-alpha + H2O | UCHL1 deubiquitinates, thereby resulting in nuclear factor-kappa B inactivation | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ubiquitin carboxyl-terminal hydrolase L1 | - |
Homo sapiens |
UCHL1 | - |
Homo sapiens |